[HTML][HTML] Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice
Y Tanaka, JK Chambers, T Matsuwaki… - Acta neuropathologica …, 2014 - Springer
Acta neuropathologica communications, 2014•Springer
Introduction It has been shown that progranulin (PGRN) deficiency causes age-related
neurodegenerative diseases such as frontotemporal lobar degeneration (FTLD) and
neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. Previous studies also
suggested that PGRN is involved in modulating lysosomal function. To elucidate the
pathophysiological role of PGRN in the aged brain, in the present study, lysosomal function
and pathological changes of the brain were investigated using 10-and 90-week-old wild …
neurodegenerative diseases such as frontotemporal lobar degeneration (FTLD) and
neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. Previous studies also
suggested that PGRN is involved in modulating lysosomal function. To elucidate the
pathophysiological role of PGRN in the aged brain, in the present study, lysosomal function
and pathological changes of the brain were investigated using 10-and 90-week-old wild …
Introduction
It has been shown that progranulin (PGRN) deficiency causes age-related neurodegenerative diseases such as frontotemporal lobar degeneration (FTLD) and neuronal ceroid lipofuscinosis (NCL), a lysosomal storage disease. Previous studies also suggested that PGRN is involved in modulating lysosomal function. To elucidate the pathophysiological role of PGRN in the aged brain, in the present study, lysosomal function and pathological changes of the brain were investigated using 10- and 90-week-old wild-type and PGRN-deficient mice.
Results
We showed that PGRN deficiency caused enhanced CD68 expression in activated microglia and astrogliosis in the cortex and thalamus, especially in the ventral posteromedial nucleus/ventral posterolateral nucleus (VPM/VPL), in the aged brain. Immunoreactivity for Lamp1 (lysosome marker) in the VPM/VPL and expression of lysosome-related genes, i.e. cathepsin D, V-type proton ATPase subunit d2, and transcription factor EB genes, were also increased by PGRN deficiency. Aggregates of p62, which is selectively degraded by the autophagy-lysosomal system, were observed in neuronal and glial cells in the VPM/VPL of aged PGRN-deficient mice. TAR DNA binding protein 43 (TDP-43) aggregates in the cytoplasm of neurons were also observed in aged PGRN-deficient mice. PGRN deficiency caused enhanced expression of glial cell-derived cytotoxic factors such as macrophage expressed gene 1, cytochrome b-245 light chain, cytochrome b-245 heavy chain, complement C4, tumor necrosis factor-α and lipocalin 2. In addition, neuronal loss and lipofuscinosis in the VPM/VPL and disrupted myelination in the cerebral cortex were observed in aged PGRN-deficient mice.
Conclusions
The present study shows that aged PGRN-deficient mice present with NCL-like pathology as well as TDP-43 aggregates in the VPM/VPL, where a particular vulnerability has been reported in NCL model mice. The present results also suggest that these pathological changes in the VPM/VPL are likely a result of lysosomal dysfunction. How PGRN prevents lysosomal dysfunction with aging remains to be elucidated.
Springer